Explorer les evidences

12 %In Cameroon, 12% of children under five years were overweight or obese according to the 2018 Demographic and Health Survey.

Camerounobésitéobservé 2018publié 2023BMC public healtheurope_pmcdocument de 2 observations

95 %The treatment gap for epilepsy is greater than 95% in 7 of the 11 African countries included in the study.

CamerounépilepsieHAL · Unilimdocument de 53 observations

11 %Microscopy detected P. falciparum/P. malariae co-infection in 11% of participants.

Camerounpaludismeobservé November 2020publié 2023Parasites & vectorseurope_pmcdocument de 16 observationsDOI 10.1186/s13071-022-05635-7

177 countriesIn 2022, obesity prevalence was higher than underweight with posterior probability of at least 0.80 in 177 countries (89%) for women and 145 countries (73%) for men.

Camerounmalnutrition · obésitéobservé 2022publié 2024Lancet (London, England)europe_pmcdocument de 9 observations

25 %The percentage of the diabetic population who were using oral diabetes drugs had a median of 25%.

Cameroundiabète (non précisé)observé 2005-15publié 2016The lancet. Diabetes & endocrinologyeurope_pmcdocument de 10 observations

42,3 %The prevalence of G6PD deficiency was 42.3% in KPD patients, 16.9% in T2DM patients, and 16.4% in normoglycemic controls.

Cameroundéficit en G6PD · ketosis-prone diabetespublié 2005The Journal of clinical endocrinology and metabolismeurope_pmcdocument de 3 observations

90 %P. falciparum is responsible for more than 90% of malaria infections in both Mfou and Tibati.

CamerounpaludismeHAL · Unilimdocument de 106 observations

4 %In Cameroon, 4 out of 90 participants had moderate eGFR impairment (45–59 mL/min), representing 4%.

Camerounmaladie rénale chroniqueHAL · Unilimdocument de 205 observations

35,3 %Among those with new-onset ketotic-phase ketosis-prone diabetes, 35.3% were positive for HHV8 antibodies.

CamerounHHV8 · ketosis-prone diabetespublié 2018Journal of diabeteseurope_pmcdocument de 10 observations

95 %The vast majority, > 95%, of malaria infections were due to Plasmodium falciparum.

CamerounpaludismeHAL · Unilimdocument de 106 observations

2 hospitalisations_par_moisAu Cameroun, la fréquence des hospitalisations pour drépanocytose est estimée à 2 hospitalisations par mois chez les adultes.

CameroundrépanocytoseHAL · Unilimdocument de 75 observations

47,3 %47.3% of participants were insulin resistant.

Camerouninsulin resistancepublié 2017BMJ openeurope_pmcdocument de 7 observations

31 %Thirty-one percent of the recruited women were diagnosed with hyperglycemia during labor.

Camerounhyperglycaemiaobservé 2013publié 2016Journal of health, population, and nutritioneurope_pmcdocument de 3 observations

11,8 %The lowest estimated lifetime risk of stroke according to GBD region was in eastern sub-Saharan Africa at 11.8%.

CamerounAVCobservé 2016publié 2018The New England journal of medicineeurope_pmcdocument de 12 observations

43,6 %The R211K accessory mutation associated with NRTI resistance was observed in 43.6% of the 142 HIV-1 samples.

CamerounVIH/sidapublié 2000Journal of Clinical MicrobiologyOpenAlexdocument de 19 observations

77,7 %Among patients with type 1 diabetes diagnosed with dyslipidaemia, statin use increased from 77.7% in wave 1 to 90.7% in wave 7.

Cameroundiabète de type 1 · dyslipidemiapublié 2021Diabetologiaeurope_pmcdocument de 14 observations

26 %The L10I/V mutation was identified in 26% of the 142 HIV-1 isolates in the protease gene.

CamerounVIH/sidapublié 2000Journal of Clinical MicrobiologyOpenAlexdocument de 19 observations

12,3 %A previous history of foot lesions was reported by 37 patients (12.3%).

Camerounfoot lesionspublié 2006The international journal of lower extremity woundseurope_pmcdocument de 10 observations

46,8 %Co-infection rates of 46.8% were found among pregnant women in Cameroon.

Camerounmalaria and schistosomiasisHAL · Unilimdocument de 74 observations

6 %If post-2000 trends continue, by 2025 severe obesity will surpass 6% in men.

Camerounobésitéobservé 2025publié 2016Lancet (London, England)europe_pmcdocument de 20 observations

5,3 %Pretreatment HIV drug resistance (PDR) prevalence among ART initiators with no prior exposure to antiretrovirals in rural areas of Cameroon was 5.3% (95% CI 1.4%–17.5%).

CamerounVIH/sidaobservé 2015publié 2018The Journal of antimicrobial chemotherapyeurope_pmcdocument de 12 observationsDOI 10.1093/jac/dky221

21,7 %The 10-year risk for coronary artery disease was between 10 and 20% in 21.7% of subjects.

Camerouncoronary artery diseasepublié 2007Cardiovascular journal of Africaeurope_pmcdocument de 4 observations

13,1 %Syndromic hearing loss accounted for 13.1% of genetic cases among patients with severe hearing loss in Cameroon.

Camerounsyndromic hearing losspublié 2013European journal of medical geneticseurope_pmcdocument de 8 observations

8,4 %The prevalence of diabetes among HIV patients in this study was 8.4%.

Cameroundiabète (non précisé)publié 2022Medicineeurope_pmcdocument de 12 observations

542 000 deathsIn 2017, stomach cancer caused 542,000 deaths in men.

Camerounstomach cancerobservé 2017publié 2019JAMA oncologyeurope_pmcdocument de 25 observationsDOI 10.1001/jamaoncol.2019.2996